Fig. 2: Pathogenesis and pathophysiology of DR. | Eye

Fig. 2: Pathogenesis and pathophysiology of DR.

From: New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway

Fig. 2

Adapted from Ansari et al. [26]. Additional links shown in red are based on publications by Kang et al. [27], Cerani et al. [28], Joyal et al. [17], Lechner et al. [2], Khanh Vu et al. [29] and Zhou et al. [30]. Adapted under the open-access Creative Commons Attribution license. Ang angiopoietin, DME diabetic macular edema, DR diabetic retinopathy, IGF-1 insulin-like growth factor 1, PDR proliferative DR, PKC protein kinase C, Sema3A semaphorin 3A, VEGF vascular endothelial growth factor.

Back to article page